Suppr超能文献

抑制多药耐药蛋白1的黄酮醇衍生物的鉴定:一种克服癌症多药耐药性的策略。

Identification of flavonol derivatives inhibiting MDR1: a strategy to overcome multidrug resistance in cancer.

作者信息

Kang Min-Ji, Lee Kyeong-Ryoon, Choi You-Jin, Chae Yoon-Jee

机构信息

College of Pharmacy, Woosuk University, Wanju, Republic of Korea.

Laboratory Animal Resource Center, Korea Research Institute of Bioscience and Biotechnology, Cheongju, Republic of Korea.

出版信息

Nat Prod Res. 2024 Nov 5:1-9. doi: 10.1080/14786419.2024.2420333.

Abstract

Multidrug resistance is a crucial factor contributing to the failure of cancer treatment. Multidrug resistance protein 1 (MDR1) is the most relevant efflux transporter associated with multidrug resistance. The objective of this study was to identify potent MDR1 inhibitors from flavonols. Fifteen flavonols were identified as inhibitors of MDR1 , with four compounds exhibiting strong inhibitory activity, having IC values below 5 μM. These potent MDR1 inhibitors were found to enhance chemosensitivity to doxorubicin in MDR1-overexpressing cells. The results of the multiple-factor analysis indicated that the 3, 5, and 6-methoxy groups were crucial for enhancing the inhibitory effects on MDR1. Furthermore, the total number of methoxy groups in the flavonol backbone was found to be a significant factor in determining the potency of MDR1 inhibition. These observations provide fundamental insights into the structure-activity relationship between flavonol derivatives and MDR1 inhibition, potentially aiding in overcoming drug resistance in cancer.

摘要

多药耐药性是导致癌症治疗失败的关键因素。多药耐药蛋白1(MDR1)是与多药耐药性最相关的外排转运蛋白。本研究的目的是从黄酮醇中鉴定出有效的MDR1抑制剂。15种黄酮醇被鉴定为MDR1抑制剂,其中4种化合物表现出强抑制活性,IC值低于5μM。这些有效的MDR1抑制剂被发现可增强对过表达MDR1的细胞中阿霉素的化疗敏感性。多因素分析结果表明,3、5和6位甲氧基对于增强对MDR1的抑制作用至关重要。此外,发现黄酮醇主链中甲氧基的总数是决定MDR1抑制效力的重要因素。这些观察结果为黄酮醇衍生物与MDR1抑制之间的构效关系提供了基本见解,可能有助于克服癌症中的耐药性。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验